251 results
Search Results
2. A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
3. The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system
4. Oral minoxidil for late alopecia in cancer survivors
5. Outcomes of older adults with early-stage triple-negative breast cancer (TNBC) receiving chemotherapy: a single-institution experience
6. Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of breast cancer? A population-based, propensity score matched cohort study
7. Body composition and chemotherapy toxicity among women treated for breast cancer: a systematic review
8. Metabolic Heterogeneity and Potential Immunotherapeutic Responses Revealed by Single-Cell Transcriptomics of Breast Cancer
9. In Vitro Study of Sonodynamic Therapy Using Gemcitabine-Loaded PEG-Gold Nanoparticles Against MCF-7 Breast Cancer Cells
10. SPDYC serves as a prognostic biomarker related to lipid metabolism and the immune microenvironment in breast cancer
11. Influence of Fragmented Human DNA on the Relationship between MicroRNA (miR-21, -221, -222, and -429) of the Lymph and the Structure of the Thymus after Surgical Treatment and Chemotherapy for Breast Cancer
12. Racial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia
13. Efficacy of a Virtual Reality Intervention for Reducing Anxiety, Depression, and Increasing Disease Coping in Patients with Breast Cancer Before Their First Chemotherapy Dose
14. Subgroups of cognitively affected and unaffected breast cancer survivors after chemotherapy: a data-driven approach
15. Expression Significance of Estrogen Receptor ER-α36 in Breast Cancer Treated by Chemotherapy: A Meta-Analysis
16. Multifractal analysis of MRI. images from breast cancer patients
17. The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer’s Association (NIA-AA)
18. Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study
19. Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system
20. Body composition and chemotherapy toxicities in breast cancer: a systematic review of the literature
21. Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores
22. Counseling young women with early breast cancer on fertility preservation
23. Influence of Chemotherapy on the Relationship between MicroRNA Levels in the Lymph with Thymus Structure in Experimental Breast Cancer
24. Brain gray matter reduction and premature brain aging after breast cancer chemotherapy: a longitudinal multicenter data pooling analysis
25. Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells
26. Optimizing the Treatment for Pregnancy-Associated Breast Cancer: a Case Example and Review of the Literature
27. Fullerenol-Based Intracellular Delivery of Methotrexate: A Water-Soluble Nanoconjugate for Enhanced Cytotoxicity and Improved Pharmacokinetics
28. Behavioral and biologic characteristics of cancer-related cognitive impairment biotypes
29. The Effect of Spirituality on Psychological Resilience in Women with Breast Cancer Who Have Received Chemotherapy: A Cross-sectional Study from Turkey
30. Comparison of goserelin and leuprorelin for ovarian protection during chemotherapy in young patients with breast cancer
31. Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study
32. Mechanistic and thermal characterization of acupuncture for chemotherapy-induced peripheral neuropathy as measured by quantitative sensory testing
33. Cortical thinning in chemotherapy-treated older long-term breast cancer survivors
34. Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment
35. Management of Pregnancy Associated Breast Cancer: a Review
36. Coping self-efficacy, perceived helpfulness of coping, and distress: a longitudinal investigation of breast and gynecologic cancer patients undergoing chemotherapy
37. Correlation of Cytokine Content in the Lymph with the Morphological Parameters of the Mesenteric Lymph Nodes in Adjuvant Therapy of Experimental Breast Cancer with the Use of Fragmented Human DNA
38. Impact of body mass index on survival in women receiving chemotherapy for early breast cancer
39. Treatment of HR+/HER2− breast cancer in urban mainland China: results from the CancerMPact Survey 2019
40. The influence of body mass index on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in women with early-stage breast cancer
41. A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
42. Impact of genomic assays on treatment and outcomes in locally advanced breast cancer
43. Ambra1 regulates apoptosis and chemosensitivity in breast cancer cells through the Akt-FoxO1-Bim pathway
44. Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA
45. Focal white matter microstructural alteration after anthracycline-based systemic treatment in long-term breast cancer survivors: a structural magnetic resonance imaging study
46. Chemotherapy for ipsilateral breast tumor recurrence: a propensity score-matching study
47. Effect of chemotherapy on default mode network connectivity in older women with breast cancer
48. Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis
49. Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis
50. Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict)
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.